is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Allan Thygesen, who is the CEO of Docusign. You know Docusign; it’s the platform ...
Docusign will summarize your contracts before you sign to make sure you understand them Businesses can also use AI to speed up preparation and reduce the chances of errors Docusign's AI is also ...
Shares of electronic signature company DocuSign (NASDAQ:DOCU) fell 5.6% in the afternoon session after a wave of competitive anxiety hit the enterprise software sector sparked by a high-profile ...
For people signing documents like leases or purchases agreements, a new AI feature will make it possible to request an overall summary of the contract and its key terms. Users will also be able to ask ...
DocuSign (DOCU) reported Q3 revenue of $818.35M and adjusted EPS of $1.01. Both metrics beat expectations. DocuSign generated $262.9M in free cash flow, up 25% year over year. Non-GAAP gross margin ...
Q3 Earnings: DocuSign reported third-quarter revenue of $813.35 million, beating the consensus estimate of $806.92 million. The intelligent agreement management company reported third-quarter adjusted ...
Docusign, Inc. (NASDAQ:DOCU) shares rose on Thursday after the company introduced a new way to integrate contract management directly into ChatGPT. • DOCU is in negative territory. Track the action ...
DocuSign (DOCU) is trying to keep up with OpenAI (OPAI.PVT). "It is the fastest pace of technology development that I've experienced in my many decades in tech," DocuSign CEO Allan Thygesen said on ...
Shares of DocuSign dropped this week after OpenAI released a new competitor in the space, DocuGPT. DocuGPT and DocuSign will have many similar capabilities. However, DocuSign has years' worth of ...
Phishing scams are getting smarter, and one of the latest tricks involves fake DocuSign emails that appear to show charges from major companies like Apple. At first glance, these fraud messages look ...
Docusign's recent correction creates a buy opportunity, hinging on cheap valuations and potential growth rebound from IAM product expansion. Growth concerns are valid due to slowing billings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results